1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Business Review Q4 2016

Biosimilars Business Review Q4 2016

  • December 2016
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - US Biosimilar Approvals To Rise In 2017 But Interchangeability Will Hamper Progress
Industry Trend Analysis - Amjevita Approval Reinforces Amgen's Biosimilar Market View
Industry Brief - Cinfa Commences Second Pegfilgrastim Study
Industry Trend Analysis - Shire Turns Away From Biosimilars
Industry Brief - MAA For Biosimilar Trastuzumab Accepted For EMA Review
Industry Trend Analysis - Celltrion Agreement Will Reinvigorate Teva's Biosimilar Efforts
Industry Brief - FDA Accepts Coherus' Biosimilar Pegfilgrastim
Industry Trend Analysis - Arthritis Set To Lead Field In New Autoimmune Drugs
Industry Trend Analysis - South Africa Will Be The First Stage In Cipla's Wider Biosimilar Ambitions
Industry Trend Analysis - Adalimumab Taking Shape As Next Major Biosimilar Competition Market
Industry Brief - Inflectra Launched In US
Industry Trend Analysis - Sandoz' Biopharmaceuticals Improving But Yet To Fulfil Potential
Industry Trend Analysis - Biosimilar Progress Will Transform Biocon's Business
Industry Trend Analysis - EC Encouraging Acceptance Of Biosimilars
Industry Trend Analysis - Momenta Set To Achieve Profitability In FY17
Industry Brief - USPTO Denies Coherus' Adalimumab Patent Review
Industry Trend Analysis - Mylan/Biocon Collaboration Will Reap Rewards In 2017
Industry Trend Analysis - Regional Spread To Sustain Gedeon Richter Until Biosimilar Programme Bears Fruit
Industry Brief - Eagle To Acquire Arsia
Industry Trend Analysis - AB 215 BLA Will Threaten Avastin's Largest Market
Industry Trend Analysis - Questioning Interchangeability Will Protect Remicade Revenues
Industry Brief - Mabion Enters Biosimilar Agreement With Mylan
Industry Brief - Study Shows Similarity Of Sandoz' Etanercept To Originator
Industry Brief - EMA Accepts MAA For CHS-1701
Industry Brief - Positive Top-Line Phase III Results For Momenta's Adalimumab
Industry Brief - Positive Top Line Results For Pfizer's Biosimilar Trastuzumab
Industry Trend Analysis - JHL Agreement Positions Sanofi To Capitalise On Underdeveloped Chinese Market
Industry Brief - Amgen And Allergan Submit ABP 215 MAA To EMA

Table Of Contents

Biosimilars Business Review Q4 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Biosimilar Drug Market Research Report 2016

Global Biosimilar Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Biosimilar Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilar Drug industry, focusing on the main regions ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.